nature.com search

Loading Filters

Showing 1–20 of 20 results

Loading Filters

27 July 2010 | Open
Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria
- T Hamaoka
- , C M Costelloe
- , J E Madewell
- , P Liu
- , G N Hortobagyi
- & N T Ueno
British Journal of Cancer 103 , 927–927

Rights & permissionsfor article Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria . Opens in a new window.
Research | 26 July 2004
Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response
- P Anderlini
- , S A Acholonu
- , G-J Okoroji
- , B S Andersson
- , D R Couriel
- , M J De Lima
- , M L Donato
- , I F Khouri
- , S A Giralt
- , N T Ueno
- & R E Champlin
Bone Marrow Transplantation 34 , 511–514

Rights & permissionsfor article Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response . Opens in a new window.
17 July 2006
Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation
- M H Qazilbash
- , N T Ueno
- , C Hosing
- , M De Lima
- , J Cortes
- , A Massaro
- , Z Rivera
- , M Deavers
- , J A Adachi
- & R E Champlin
Bone Marrow Transplantation 38 , 393–394

Rights & permissionsfor article Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation . Opens in a new window.
Editorial | 15 November 2006
The future of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma in the era of target-specific therapy
- N T Ueno
- & Y C Cheng
Bone Marrow Transplantation 38 , 711–714

Rights & permissionsfor article The future of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma in the era of target-specific therapy . Opens in a new window.
2 July 2013 | Open
Statin use in primary inflammatory breast cancer: a cohort study
- T M Brewer
- , H Masuda
- , D D Liu
- , Y Shen
- , P Liu
- , T Iwamoto
- , K Kai
- , C M Barnett
- , W A Woodward
- , J M Reuben
- , P Yang
- , G N Hortobagyi
- & N T Ueno
British Journal of Cancer 109 , 318–324

Rights & permissionsfor article Statin use in primary inflammatory breast cancer: a cohort study . Opens in a new window.
Research | 17 December 2007
Allogeneic hematopoietic cell transplantation for metastatic breast cancer
- N T Ueno
- , J D Rizzo
- , T Demirer
- , Y C Cheng
- , U Hegenbart
- , M-J Zhang
- , M Bregni
- , A Carella
- , D Blaise
- , A Bashey
- , J D Bitran
- , B J Bolwell
- , G J Elfenbein
- , K K Fields
- , C O Freytes
- , R P Gale
- , H M Lazarus
- , R E Champlin
- , P J Stiff
- & D Niederwieser
Bone Marrow Transplantation 41 , 537–545

Rights & permissionsfor article Allogeneic hematopoietic cell transplantation for metastatic breast cancer . Opens in a new window.
Research | 2 April 2012
Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis
- R J Cook
- , Z Wang
- , M Arora
- , H M Lazarus
- , K A Kasow
- , M A Champagne
- , W Saber
- , K M van Besien
- , G A Hale
- , E A Copelan
- , M Elmongy
- , N T Ueno
- , B N Horn
- , S Slavin
- , M R Bishop
- & E A Stadtmauer
Bone Marrow Transplantation 47 , 1455–1458

Rights & permissionsfor article Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis . Opens in a new window.
Research | 10 June 2003
Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer
- R Wong
- , G Rondon
- , R M Saliba
- , V R Shannon
- , S A Giralt
- , R E Champlin
- & N T Ueno
Bone Marrow Transplantation 31 , 1157–1163

Rights & permissionsfor article Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer . Opens in a new window.
Research | 27 March 2006
High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy
- N T Ueno
- , S Konoplev
- , T A Buchholz
- , T Smith
- , G Rondón
- , P Anderlini
- , S A Giralt
- , J L Gajewski
- , M L Donato
- , M Cristofanilli
- & R E Champlin
Bone Marrow Transplantation 37 , 929–935

Rights & permissionsfor article High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy . Opens in a new window.
Research | 18 November 2005
Reduction of radiation-induced apoptosis by specific expression of Bcl-2 in normal cells
- H Itamochi
- , F Yamasaki
- , T Sudo
- , T Takahashi
- , C Bartholomeusz
- , S Das
- , N Terakawa
- & N T Ueno
Cancer Gene Therapy 13 , 451–459

Rights & permissionsfor article Reduction of radiation-induced apoptosis by specific expression of Bcl-2 in normal cells . Opens in a new window.
26 January 2010 | Open
Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer
- T Hamaoka
- , C M Costelloe
- , J E Madewell
- , P Liu
- , D A Berry
- , R Islam
- , R L Theriault
- , G N Hortobagyi
- & N T Ueno
British Journal of Cancer 102 , 651–657

Rights & permissionsfor article Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer . Opens in a new window.
Research | 18 May 2009
Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer
- J A de Souza
- , M L Davis
- , G Rondon
- , Y C Cheng
- , R B Jones
- , R E Champlin
- & N T Ueno
Bone Marrow Transplantation 44 , 81–87

Rights & permissionsfor article Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer . Opens in a new window.
Research | 4 April 2005
Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen
- P Anderlini
- , R Saliba
- , S Acholonu
- , G-J Okoroji
- , M Donato
- , S Giralt
- , B Andersson
- , N T Ueno
- , I Khouri
- , M De Lima
- , C Hosing
- , A Cohen
- , C Ippoliti
- , J Romaguera
- , M A Rodriguez
- , B Pro
- , L Fayad
- , A Goy
- , A Younes
- & R E Champlin
Bone Marrow Transplantation 35 , 943–951

Rights & permissionsfor article Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen . Opens in a new window.
28 September 2010 | Open
Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients
- Y C Cheng
- , V Valero
- , M L Davis
- , M C Green
- , A M Gonzalez-Angulo
- , R L Theriault
- , J L Murray
- , G N Hortobagyi
- & N T Ueno
British Journal of Cancer 103 , 1331–1334

Rights & permissionsfor article Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients . Opens in a new window.
Research | 12 December 2016
c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun
- X Xie
- , T S Kaoud
- , R Edupuganti
- , T Zhang
- , T Kogawa
- , Y Zhao
- , G B Chauhan
- , D N Giannoukos
- , Y Qi
- , D Tripathy
- , J Wang
- , N S Gray
- , K N Dalby
- , C Bartholomeusz
- & N T Ueno
Oncogene 36 , 2599–2608

Rights & permissionsfor article c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun . Opens in a new window.
Research | 19 September 2005
Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15
- C Bartholomeusz
- , H Itamochi
- , M Nitta
- , H Saya
- , M H Ginsberg
- & N T Ueno
Oncogene 25 , 79–90

Rights & permissionsfor article Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15 . Opens in a new window.
Research | 4 February 2013
Ink4a/Arf^−/− and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f⁻ quiescent cells
- K Kai
- , T Iwamoto
- , T Kobayashi
- , Y Arima
- , Y Takamoto
- , N Ohnishi
- , C Bartholomeusz
- , R Horii
- , F Akiyama
- , G N Hortobagyi
- , L Pusztai
- , H Saya
- & N T Ueno
Oncogene 33 , 440–448

Rights & permissionsfor article Ink4a/Arf−/− and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f− quiescent cells . Opens in a new window.
Research | 18 February 2013
Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience
- G A Hale
- , M Arora
- , K W Ahn
- , W He
- , B Camitta
- , M R Bishop
- , M Bitan
- , M S Cairo
- , K Chan
- , R W Childs
- , E Copelan
- , S M Davies
- , M A D Perez
- , J J Doyle
- , R P Gale
- , M G Vicent
- , B N Horn
- , A A Hussein
- , S Jodele
- , N R Kamani
- , K A Kasow
- , M Kletzel
- , H M Lazarus
- , V A Lewis
- , K C Myers
- , R Olsson
- , M Pulsipher
- , M Qayed
- , J E Sanders
- , P J Shaw
- , S Soni
- , P J Stiff
- , E A Stadtmauer
- , N T Ueno
- , D A Wall
- & S A Grupp
Bone Marrow Transplantation 48 , 1056–1064

Rights & permissionsfor article Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience . Opens in a new window.
Research | 16 July 2012 | Open
PEA-15 unphosphorylated at both serine 104 and serine 116 inhibits ovarian cancer cell tumorigenicity and progression through blocking β-catenin
- J Lee
- , C Bartholomeusz
- , S Krishnamurthy
- , P Liu
- , H Saso
- , T A LaFortune
- , G N Hortobagyi
- & N T Ueno
Oncogenesis 1 , e22–e22

Rights & permissionsfor article PEA-15 unphosphorylated at both serine 104 and serine 116 inhibits ovarian cancer cell tumorigenicity and progression through blocking β-catenin . Opens in a new window.
News and Views | 4 September 2006
The Second International Meeting on Allogeneic Transplantation in Solid Tumors
- M Bregni
- , N T Ueno
- & R Childs
Bone Marrow Transplantation 38 , 527–537

Rights & permissionsfor article The Second International Meeting on Allogeneic Transplantation in Solid Tumors . Opens in a new window.

Refine your results by…

Filters

Filter By:

Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria

Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response

Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation

The future of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma in the era of target-specific therapy

Statin use in primary inflammatory breast cancer: a cohort study

Allogeneic hematopoietic cell transplantation for metastatic breast cancer

Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis

Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer

High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy

Reduction of radiation-induced apoptosis by specific expression of Bcl-2 in normal cells

Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer

Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer

Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen

Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients

c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun

Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15

Ink4a/Arf^−/− and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f⁻ quiescent cells

Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience

PEA-15 unphosphorylated at both serine 104 and serine 116 inhibits ovarian cancer cell tumorigenicity and progression through blocking β-catenin

The Second International Meeting on Allogeneic Transplantation in Solid Tumors

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters